NIH halts clinical trial of hydroxychloroquine after finding no benefit to coronavirus patients

Canada News News

NIH halts clinical trial of hydroxychloroquine after finding no benefit to coronavirus patients
Canada Latest News,Canada Headlines
  • 📰 CNBC
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 72%

The National Institutes of Health has halted its clinical trial of the anti-malaria drug hydroxychloroquine after finding that the treatment provides no benefit to COVID-19 patients.

The decision to end the trial comes after the Food and Drug Administration revoked emergency use of the drug on Monday and the World Health Organization dropped the drug from its global study on Wednesday.

There are no FDA-approved drugs to treat the coronavirus, which has infected more than 8.6 million people worldwide and killed at least 460,594, according to data from Johns Hopkins University. The drug hydroxychloroquine, pushed by U.S. President Donald Trump and others in recent months as a possible treatment to people infected with the coronavirus disease , is displayed at the Rock Canyon Pharmacy in Provo, Utah, May 27, 2020.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

CNBC /  🏆 12. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Fergus Walsh: At last some good news about coronavirusFergus Walsh: At last some good news about coronavirusHow the biggest trial in the world found life-saving coronavirus drug dexamethasone in record time.
Read more »

Coronavirus pandemic threatens to delay potentially life-changing, new medicinesCoronavirus pandemic threatens to delay potentially life-changing, new medicinesThe coronavirus disrupted the start of new clinical trials for potentially life-changing, new medicines and now may delay the time in which some of those drugs will reach the market.
Read more »

Osteoporosis drug shows promise against coronavirusOsteoporosis drug shows promise against coronavirusEU-backed researchers are requesting clinical trials to study the osteoporosis drug Raloxifene after virtual and laboratory tests suggest it could be active against the COVID-19 virus
Read more »

Kids With COVID-19 Are Set To Be Enrolled in a 'Promising' New Clinical Drug TrialKids With COVID-19 Are Set To Be Enrolled in a 'Promising' New Clinical Drug TrialDrugmaker Gilead is launching a new pediatric clinical with their promising coronavirus drug, remdesivir, in the US and across Europe.
Read more »

What we do know — and don’t know — about the coronavirus at day 100 of the pandemicWhat we do know — and don’t know — about the coronavirus at day 100 of the pandemic100 days of the coronavirus pandemic. What have we learned? - Once-promising drugs have failed - The virus spreads more by droplets and aerosols rather than shared surfaces - Masks can prevent transmission
Read more »

Coronavirus antibodies may disappear 2 to 3 months after people recover, a new study foundCoronavirus antibodies may disappear 2 to 3 months after people recover, a new study foundAsymptomatic people had "weaker" immune responses to COVID-19, and 40% of them had no detectable antibodies after a couple of months.
Read more »



Render Time: 2025-03-10 07:33:48